Memphis, TN, United States of America

Supriya A Bavadekar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of Mississippi, The University of Tennessee Research Foundation. Active years: 2008.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Supriya A Bavadekar: Innovator in Yohimbine Derivatives

Introduction

Supriya A Bavadekar is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of pharmacology, particularly through her innovative work on yohimbine derivatives. Her research focuses on the modification of the C-16 carboxyl group in yohimbine, leading to new compounds with potential therapeutic applications.

Latest Patents

Supriya A Bavadekar holds a patent for "Yohimbine derivatives and use thereof." This patent describes yohimbine derivatives that include modifications to the C-16 carboxyl group, resulting in compounds that do not possess a second yohimbine pharmacophore. The derivatives are characterized by selective activity as α-AR antagonists. The patent also discusses the use of these compounds, or pharmaceutical compositions containing them, for treating or preventing α-adrenergic receptor-mediated conditions or disorders.

Career Highlights

Throughout her career, Supriya has worked with esteemed institutions such as the University of Tennessee Research Foundation and the University of Mississippi. Her work has contributed to advancements in the understanding and application of yohimbine derivatives in medical treatments.

Collaborations

Supriya has collaborated with notable colleagues, including Duane Douglas Miller and Bob M Moore, II. These partnerships have enhanced her research and expanded the impact of her innovations in the field.

Conclusion

Supriya A Bavadekar is a pioneering inventor whose work on yohimbine derivatives showcases her commitment to advancing pharmacological research. Her contributions have the potential to lead to new treatments for various medical conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…